Searchable abstracts of presentations at key conferences in endocrinology

ea0026p682 | Diabetes therapy | ECE2011

The addition of acipimox in patients with type 2 diabetes with triglyceride level over 150 mg/dl in spite of fenofibrate therapy

Kim D-M , Park J R

Patients with type 2 diabetes have an increased risk of premature coronary heart disease (CHD). One of the underlying reasons for this increased risk is atherogenic dyslipidemia. Current management strategies focus on the initial use of statin or fibrate therapy (the latter approach indicated in patients with pronounced hypertriglyceridemia).American Diabetes Association recognizes serum triglycerides as a surrogate for atherogenic triglyceride-rich lipo...

ea0049ep598 | Diabetes therapy | ECE2017

The hypolipidemic and hepatoprotective efficacies of a fixed-dose combination of essential phospholipids with methionine (EPL+M) during atorvastatin (A) therapy in hyperlipidemic patients with cardiovascular diseases (CVD) and type 2 diabetes mellitus (DM) (OLYMP trial)

Bubnova M G , Aronov D M , Bubnoa Marina , Aronov David

Objective: Objective to study the hypolipidemic efficacy, hepatoprotective activity, and tolerance of the fixed-dose combination of essential phospholipids with methionine (EPL+M) - Eslidine in the combination therapy with A in patients (pts) with cardiovascular diseases (CVD) and type 2 DM who suffer from hyperlipidemia (HL) in order to optimize their treatment in daily clinical practice.Subjects and methods: The trial enrolled 60 pts (mean age 58.1&#17...

ea0039ep112 | Pituitary and growth | BSPED2015

Skeletal disproportion in Turner syndrome

McVey L , Fletcher A , Donaldson M D , Wong S C , Mason A

Aims: The aim of this study is to evaluate sitting height (SH) and leg length (LL) in girls with Turner syndrome.Methods: Retrospective study of SH and LL SDS, using SH–LL SDS (~0 in a proportionate child) as a measure of disproportion in 76 girls with Turner syndrome. Eligible girls were aged at least 4 years, had not started recombinant GH, and had no other chronic disease. 40 girls with measurements prior to pubertal induction and at adult height...

ea0024p57 | (1) | BSPED2010

Retrospective audit of endocrine late effects in survivors of childhood cancer

Balapatabendi M D , Srinivasan J , Greening J , Ross E

Introduction: The Paediatric Oncology Late Effects Clinic in Leicester was established in 1999, in order to monitor cancer survivors for the development of secondary co-morbidity, including that relating to endocrinopathy from treatment for the underlying oncological diseases.Aim: As a retrospective audit of our clinical service against the current existing guidelines (UKCSSG, SIGN), specifically to monitor the endocrine standards with respect to axiolog...

ea0077p112 | Reproductive Endocrinology | SFEBES2021

What is the prevalence and pattern of cancers in Turner syndrome? A single centre cohort study

Goindoo Ryan J , Dilrukshi M D S A , Bragg Fiona , Calanchini Matilde , Turner Helen

Background: Previous population studies suggest cancer morbidity is different in Turner syndrome (TS) compared to the background female population. Whilst gonadoblastoma is well recognized in TS with Y chromosome material, studies have suggested increased prevalence of skin tumours and meningioma but reduced incidence of breast cancer.Methods: Retrospective analysis of an adult TS clinic patient database identified women who developed cancer. Tumour type...

ea0081ep874 | Reproductive and Developmental Endocrinology | ECE2022

Have we ignored red cell parameters in Turner Syndrome? Results from a single specialist centre

Beck Katharina , Dilrukshi M d s a , Calanchini Matilde , Roy Noemi B A , Turner Helen E

Introduction: Anaemia and other haematological disorders have been reported in Turner Syndrome (TS). TS-related comorbidities (premature ovarian insufficiency, autoimmune hypothyroidism, coeliac disease and liver diseases) and treatments (hormone replacement [HRT] and growth hormone) are possible explanations. We aim to investigate the prevalence of abnormal full blood count (FBC) in adult TS and assess associated clinical characteristics.Methods: FBC pa...

ea0091we8 | Workshop E: Disorders of the gonads | SFEEU2023

A case of non obstructive azoospermia

A D M Kumarathunga P , Wellala Vindya , Yovos George , Thadani Puja , Randeva Harpal

Introduction: Infertility is a common medical condition affecting 50 million couples worldwide and azoospermia account for around 10 % of cases of male infertility. Non-obstructive azoospermia is one of the most severe forms of male infertility and aetiology could be due to primary testicular failure, secondary testicular failure and those with incomplete or ambiguous picture of testicular failure.Case report: A 34-year-old patient referred to endocrine ...

ea0041ep459 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

The risk of developing of obstructive sleep apnea syndrome in type 2 diabetes mellitus patients in Uzbek population

Ismailov S I , Esimova D M , Muminova S U , Sultanova F T , Gulyamova Kh R

Actuality: According to WHO, 36% of patients with type 2 diabetes mellitus (T2DM) suffer from obstructive sleep apnoe syndrome (OSAS), which is one of global problems of modern medicine. International classification of sleep disorders identified that 24% of men and 9% of women with T2DM observe symptoms of OSAS. Sleep apnea has a negative effect on the function of the beta cells of the pancreas and insulin sensitivity. Obstructive sleep apnea has a negative impact on the quali...

ea0034p270 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Does TCF7L2 polymorphisms increase the risk of gestational diabetes mellitus in South Indian population?

Thomas Nihal , Mahesh D M , Chapla Aaron , Paul Johan , Shwetha N , Christina Flory , Asha H S

Introduction: Genetic predisposition with environmental factors plays a significant role in the development of type 2 diabetes mellitus. Among the diabetogenic genes, the transcription factor 7-like 2 (TCF7L2), a member of the Wnt signalling pathway remains the strongest genetic determinant of type 2 diabetes risk in humans. Our aim was to investigate whether TCF7L2 variants that have previously been associated with type2 diabetes would also confer risk for gestational diabete...

ea0031p365 | Thyroid | SFEBES2013

The challenge of managing refractory amiodarone-induced Graves' disease in resistance to thyroid hormone

Moran Carla , Chatterjee V K K , Page M D , Owen Penny

A 42-year-old man with resistance to thyroid hormone (RTH) and a recognised thyroid hormone receptorβ mutation (R383C) mutation, presented with atrial fibrillation (AF) which was resistant to DC cardioversion until initiation of amiodarone therapy.As expected in RTH, his baseline TFTs were abnormal (FT4 34.6 pmol/l, TSH 2.27 mU/l), but rose further (FT4 45 pmol/l, TSH 0.93 mU/l) following commencement of amiodarone. However, sh...